Research at the Feng Laboratory at the University of California, San Francisco, focuses on the discovery of prognostic and predictive biomarkers in urological cancers, the investigation of mechanisms by which these biomarkers mediate tumor progression, and the development of therapeutic strategies targeted on these disease drivers. Our team is comprised of biologists and computational scientists working together to advance our understanding of cancer biology with the aim of improving patient outcomes.